-+ 0.00%
-+ 0.00%
-+ 0.00%

Gilead And Kite To Present Data In 1L Metastatic Triple-Negative Breast Cancer, Updated Results In Multiple Myeloma And Early Data From Investigational CAR T-Cell Therapy Targeting Brain Cancer At 2025 ASCO And EHA

Benzinga·05/15/2025 20:28:49
Listen to the news

– Late-Breaking Data from the Phase 3 ASCENT-04/KEYNOTE-D19 Study Evaluating Trodelvy® plus Keytruda® in First-Line PD-L1+ Metastatic Triple-Negative Breast Cancer –